ArticleInternational journal of legal medicine2025
Global characterization of extrachromosomal circular DNAs in four body fluids.
Article in International journal of legal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Determination of the type of body fluids is highly desired in forensic investigations. Extrachromosomal circular DNA (eccDNA) is a double-stranded, circular type of nucleic acid molecule that exists outside chromosomes and is ubiquitous in eukaryotic cells, which is widely explored in clinical research. The use of eccDNA for body fluid identification has remained relatively unexplored. As such, peripheral blood, menstrual blood, semen, and saliva samples (each = 3) from healthy individuals were detected, using Circle-seq, to identify potential markers for body fluid identification. In total, 263,036 eccDNAs were identified, widely distributed throughout the genome, and most of them were within 1000 base pairs in size. The study combined eccDNA with RNA analysis in an attempt to observe the relationship between eccDNA and gene expression in healthy individuals. We performed outward PCR on selected eccDNAs using library samples and validated the predicted junction sites by Sanger sequencing. In short, this pilot study demonstrated for the first time the characterization of eccDNA profiles from four body fluids of healthy individuals. It provided a novel direction for body fluid identification. In the future, breaking the low abundance and high heterogeneity of eccDNA will lead to new possibilities in the forensic field.
Indexed as
Identifiers
39945904What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.